National Cancer Registry

Definition	A cancer registry is defined as a location, be it an office or institution, where collection, storage, analysis and interpretation of data on cancer patients take place (Jenson et al, 1991).
Objectives	- To measure cancer incidence - To describe cancer by time, place, persons and disease - To provide a national database for further epidemiological research
Case definition	Target cases are: - Incident cases by year of diagnosis - Malignant tumors confirmed by histopathology and/or hematology findings - Cancers of all sites
Sources of data	Data are collected through two main channels: the capture system (passive reporting) and the recapture system (active reporting). 1) The capture system: The capture system is based on physician’s routine reporting of cancer cases. Physician’s complete and send forms: - Directly from their clinic; or - Indirectly through the MOPH Drug Dispensing Center (DDC), where anti-cancer drugs are distributed to eligible patients 2) The recapture system: The recapture system is based on gathering information directly from histopathological and hematological laboratories. Data are collected in various ways, using hard or soft copies, or using database file or individual laboratory results depending on laboratories resources. This process is active since the NCR personnel actually contact the sites to obtain the necessary data. The recapture system validates and complements the capture approach.
Medical coding	The coding of cancer primary sites and cancer morphology is done using International Classification of Diseases for Oncology, third edition (ICD-O-3). The code includes information on the topography (primary site), the histology, the behavior and the grade of the tumor. The structure is C##.# M####/##, where: - C##.# specifies the primary site - M#### specifies the histology - /## specifies the behavior and the grade of the tumor
Reporting form	NCR reporting form

ATC	Name	B/G	Ingredients	Dosage	Form	Price
P02CF01	IVERMECTINE BIOGARAN	G	Ivermectin - 3mg	3mg	Tablet	1,075,074 L.L
P02CF01	IVER	G	Ivermectin - 6mg	6mg	Tablet	431,373 L.L
P02CF01	IVERMECTIN BENTA	G	Ivermectin - 6mg	6mg	Tablet	784,548 L.L
P02CF01	IVERMECTIN BENTA	G	Ivermectin - 6mg	6mg	Tablet	470,985 L.L
P02DA01	TAENIASAN	G	Niclosamide - 500mg	500mg	Tablet	94,709 L.L
P02DA01	TENIADEX	G	Niclosamide - 500mg	500mg	Tablet	70,392 L.L
P03AB02	GAMMA BENZENE HEXACHLORIDE	G	Lindane - 1%	1%	Shampoo	195,817 L.L
P03AB02	GAMMAPHARM	G	Lindane - 1%	1%	Shampoo	195,817 L.L
P03AB02	GAMMA BENZENE HEXACHLORIDE	G	Lindane - 1%	1%	Lotion	167,660 L.L
P03AC04	PERMACARE	G	Permethrin - 1%	1%	Lotion	590,011 L.L
P03AX01	SPIDOGALE	G	Benzyl benzoate - 10g/100ml, Sulfur colloïdal - 5g/100ml		Lotion	207,336 L.L
R01AA05	UTABON	G	Oxymetazoline HCl - 0.5mg/ml	0.5mg/ml	Spray, solution	302,365 L.L
R01AA07	DECOZAL	G	Xylometazoline HCl - 0.05%	0.05%	Metered dose spray	108,851 L.L
R01AA07	OTRIVIN	B	Xylometazoline HCl - 0.05%	0.05%	Drops	181,419 L.L
R01AA07	XYLO-COMOD	G	Xylometazoline HCl - 0.1%	0.1%	Solution	499,909 L.L
R01AA07	OTRIVIN	B	Xylometazoline HCl - 0.1%	0.1%	Solution	260,705 L.L
R01AA07	DECOZAL	G	Xylometazoline HCl - 0.1%	0.1%	Metered dose spray	147,823 L.L
R01AA07	DECOZAL	G	Xylometazoline HCl - 0.1%	0.1%	Drops	145,135 L.L
R01AA07	OTRIVIN	B	Xylometazoline HCl - 0.1%	0.1%	Drops	241,892 L.L
R01AA07	OTRIVIN MENTHOL 0.1%	B	Xylometazoline HCl - 0.1%	0.1%	Drops	387,027 L.L
R01AA07	OTRIVIN	B	Xylometazoline HCl - 0.05%	0.05%	Solution	260,705 L.L
R01AA07	DECOZAL	G	Xylometazoline HCl - 0.05%	0.05%	Metered dose spray	155,886 L.L
R01AB01	VAPICIL MICRODOSER	G	Phenylephrine - 2.5mg/ml, Dimethindene maleate - 0.25mg/ml		Spray	239,204 L.L
R01AB06	TRIOFAN	B	Xylometazoline HCl - 0.5mg/ml, Carbocysteine - 5mg/ml		Spray, solution	608,761 L.L
R01AB06	TRIOFAN	B	Xylometazoline HCl - 1mg/ml, Carbocysteine - 10mg/ml		Spray, solution	646,388 L.L
R01AB06	NARIX	G	Xylometazoline HCl - 90mcg/actuation, Carbocisteine - 900mcg/actuation		Spray	518,339 L.L
R01AB06	OTRIVIN DUAL RELIEF	B	Xylometazoline HCl - 0.5mg/ml, Ipratropium bromide - 0.6mg/ml		Solution	563,070 L.L
R01AB08	RINOFLUIMUCIL	B	Acetylcysteine - 1%, Tuaminoheptane sulfate - 0.5%, Benzalkonium chloride - 0.0125%		Solution	419,279 L.L
R01AC03	ALLERGODIL NASAL	B	Azelastine HCl - 0.14mg/dose	0.14mg/dose	Spray, solution	657,139 L.L
R01AD08	OTRIALLERGY	B	Fluticasone propionate - 50mcg/actuation	50mcg/actuation	Spray, suspension	675,953 L.L

National Cancer Registry (NCR)